Page 33 - Prevention Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ZURICH (Reuters) — Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is ill, the U.S. drugmaker said on Monday. REGEN-COV, a combination of casirivimab and imdevimab, protected household contacts from exposure to SARS-CoV-2, with 72% protection against symptomatic infections in the first week and 93% after that, according to trial data released by the company. In a separate trial, Regeneron also said the treatment reduced overall risk of progres...

Regeneron Pharmaceuticals announced Monday that a Phase 3 trial of its antibody cocktail offered strong protection against COVID-19 for people living with someone infected with the coronavirus. The treatment lessens the likelihood of infection and improves outcomes for those who do become infected, Regeneron said in a statement. The treatment also appears to be potent against emerging variants, the company said.  The data suggests the treatment "can complement widespread vaccination strategies, particularly for those at high risk of infection," said Myron Cohen, M.D., who leads the monoc...

Regeneron Pharmaceuticals, Inc. announced positive data from a Phase 3 trial of recently infected asymptomatic COVID-19 patients, evaluating REGEN-COV ...

The federal government is not inclined to ship extra vaccine supplies to Michigan to combat the state's severe surge in cases. Latest COVID news.

Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is... | April 12, 2021